Meet Nikhil
Nikhil Mirajkar
Dr. Nikhil Mirajkar is a Consultant Radiologist specialising in Gastrointestinal and Hepatopancreatobiliary (GI/HPB) imaging at Addenbrooke’s Hospital, Cambridge University Hospitals NHS Foundation Trust, one of the UK’s leading academic medical centres.
A graduate of the University of Birmingham, Dr. Mirajkar holds a BMedSc with Honours and an MBChB, and is a Fellow of the Royal College of Radiologists (FRCR). He further honed his sub-specialist expertise as an Abdominal Imaging Fellow at the Joint Department of Medical Imaging (JDMI) in Toronto — a globally respected centre for abdominal and oncologic radiology.
In his clinical role at Addenbrooke’s, Dr. Mirajkar works at the forefront of complex abdominal imaging, contributing to multidisciplinary teams managing conditions of the liver, pancreas, biliary system, and gastrointestinal tract. His academic contributions include peer-reviewed research on IgG4-related disease (IgG4-RD), and he has been invited to speak and present cases at national and international conferences, including the British Institute of Radiology Annual Meeting (BIR2024).
Beyond his clinical practice, Dr. Mirajkar is Co-Founder and Chief Medical Officer of Labelata, a Swiss-based health-tech start-up delivering high-quality, scalable medical data segmentation and labelling through a global network of trained medical professionals — with a strong emphasis on data quality and protection. In this entrepreneurial role, he bridges the worlds of clinical medicine and artificial intelligence, helping to build the infrastructure underpinning next-generation diagnostic tools.
Dr. Mirajkar is passionate about advancing radiology through clinical excellence, research, and innovation, and brings a unique combination of specialist expertise, international training, and entrepreneurial leadership to everything he does
Book now to secure an
affordable scan today.
Tired of seeing patients' lives put on hold by long wait times and rigid scheduling, we asked ourselves:
What if patients could take control of their healthcare journey?